Close this search box.

We are creating some awesome events for you. Kindly bear with us.

A*STAR Singapore Brings Tech Innovations from Lab to Real World

Even as a newly independent country with scarce natural resources, Singapore knew that the key to its survival lay in the one thing that could help the country overcome its natural limits: science and technology.

Agency for Science, Technology and Research’s (A*STAR’s) research and development (R&D) efforts have enabled the country to address emerging challenges and seed capabilities in critical areas. But while R&D is an unquestionably valuable resource, capturing value through commercialising those research efforts is equally important.

In today’s hypercompetitive world and challenging global trade environment, innovation is a key driver for Singapore’s long-term economic growth.

– Sze Wee Tan, Assistant Chief Executive, Enterprise Division, A*STAR

A*STAR’s commercialisation initiatives have since resulted in a steady stream of landmark patents and successful collaborations, all of which have set Singapore on the path towards being an innovation-driven, knowledge-based economy, rich in job and research opportunities alike.

The Institute for Infocomm Research (I2R) took a big step forward when they produced the world’s first patented adaptive audio streaming technology. Their invention not only compressed music files with little distortion or fidelity loss, but also enabled streaming at different qualities depending on the device type or available bandwidth.

Beyond the steady stream of patents from A*STAR research institutes, A*STAR also has collaborated with several companies and the Centre of Excellence in Advanced Packaging between Applied Materials (AMAT) and the Institute of Microelectronics (IME) as stellar examples of successful R&D commercialisation. While strong patents can arise from the focused efforts of individual researchers, collaborations can generate a patent portfolio that enables platform or system applications.

A*STAR also assists other companies in translating technology into products. For example, SIMTech’s Innovation Factory provides support for Singapore SMEs from ideation to the design and engineering stage, while A*STAR’s open innovation platform A*StartCentral (A*SC) fosters an ecosystem that encourages venture creation.

A*STAR forges ahead in its mission to continue generating economic and societal impact for Singapore and the world. Guiding the agency’s efforts is the Research, Innovation and Enterprise 2025 (RIE2025) plan, which sets the blueprint for the Republic’s science and technology efforts.

A*STAR will also focus on further developing private-public partnership platforms, such as the DxD Hub and the Experimental Drug Development Centre (EDDC), which connect researchers and companies to enable the rapid production of diagnostic tests and treatments. Recognising that Singapore’s most critical resource remains its people, A*STAR intends to continue its talent development strategy to build a strong core of local scientific talent complemented by international researchers.

Since the genesis of its R&D journey decades ago, Singapore has firmly established a vibrant research and innovation ecosystem. Through the Enterprise division, A*STAR will build upon those successes and deliver even more value through science and technology.

As reported by OpenGov Asia, a team of researchers from the Agency for Science, Technology and Research’s (A*STAR) Genome Institute of Singapore (GIS) have developed software that extracts RNA modifications (an additional layer of the information above the genetic molecule RNA) from genomics data. Their research was published in Nature Biotechnology.

For RNAs, chemical molecules may change the function of the same RNA. These RNA modifications are widespread, but because they do not change the letters of the RNA, they are very difficult to identify. More than 100 RNA modifications are known to play different roles in cells. Some of these RNA modifications are associated with disease risk, while others are used in mRNA vaccines.

By collaborating with the National University Cancer Institute, Singapore (NCIS), the team successfully detected the m6A RNA modification using the AI tool in multiple myeloma cancer patient samples, showing the AI tool’s potential for large-scale clinical analyses. The scientists have been interested in studying m6A modification in myeloma as this may have important clinical and therapeutic implications for patients with poor outcomes. Now with the AI tool, they have an important tool to facilitate their studies.


Qlik’s vision is a data-literate world, where everyone can use data and analytics to improve decision-making and solve their most challenging problems. A private company, Qlik offers real-time data integration and analytics solutions, powered by Qlik Cloud, to close the gaps between data, insights and action. By transforming data into Active Intelligence, businesses can drive better decisions, improve revenue and profitability, and optimize customer relationships. Qlik serves more than 38,000 active customers in over 100 countries.


CTC Global Singapore, a premier end-to-end IT solutions provider, is a fully owned subsidiary of ITOCHU Techno-Solutions Corporation (CTC) and ITOCHU Corporation.

Since 1972, CTC has established itself as one of the country’s top IT solutions providers. With 50 years of experience, headed by an experienced management team and staffed by over 200 qualified IT professionals, we support organizations with integrated IT solutions expertise in Autonomous IT, Cyber Security, Digital Transformation, Enterprise Cloud Infrastructure, Workplace Modernization and Professional Services.

Well-known for our strengths in system integration and consultation, CTC Global proves to be the preferred IT outsourcing destination for organizations all over Singapore today.


Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions creates an organizational focus on the strategic outcomes that matter and empowers teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,300 employees supporting 4,500 customers and 2.6 million users worldwide. For more information, visit


SIRIM is a premier industrial research and technology organisation in Malaysia, wholly-owned by the Minister​ of Finance Incorporated. With over forty years of experience and expertise, SIRIM is mandated as the machinery for research and technology development, and the national champion of quality. SIRIM has always played a major role in the development of the country’s private sector. By tapping into our expertise and knowledge base, we focus on developing new technologies and improvements in the manufacturing, technology and services sectors. We nurture Small Medium Enterprises (SME) growth with solutions for technology penetration and upgrading, making it an ideal technology partner for SMEs.


HashiCorp provides infrastructure automation software for multi-cloud environments, enabling enterprises to unlock a common cloud operating model to provision, secure, connect, and run any application on any infrastructure. HashiCorp tools allow organizations to deliver applications faster by helping enterprises transition from manual processes and ITIL practices to self-service automation and DevOps practices. 


IBM is a leading global hybrid cloud and AI, and business services provider. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Nearly 3,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity and service.